Stock Report

Neuland Laboratories Ltd consolidated Q4FY23 PAT surges to Rs. 84.54 crores

Posted On : 2023-05-11 14:34:17( TIMEZONE : IST )

Neuland Laboratories Limited has reported Consolidated financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 415.1368 crores during the period ended March 31, 2023 as compared to Rs. 270.1831 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. 84.5439 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. 30.5482 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. 65.90 for the period ended March 31, 2023 as compared to Rs. 23.81 for the period ended December 31, 2022.

Financials	Q4 FY2023	Q3 FY2023	% Change
Total Income	₹415.1368 crs	₹270.1831 crs	53.65%
Net Profit	₹84.5439 crs	₹30.5482 crs	176.76%
EPS	₹65.90	₹23.81	176.77%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs.415.1368 crores during the period ended March 31, 2023 as compared to Rs.256.5040 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.84.5439 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.21.7807 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.65.90 for the period ended March 31, 2023 as compared to Rs.16.97 for the period ended March 31, 2022.

Financials	Q4 FY2023	Q4 FY2022	% Change
Total Income	₹415.1368 crs	₹256.5040 crs	61.84%
Net Profit	₹84.5439 crs	₹21.7807 crs	288.16%
EPS	₹65.90	₹16.97	288.33%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.1200.9462 crores during the Financial Year ended March 31, 2023 as compared to Rs.953.1534 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.163.5176 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.63.8220 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.127.45 for the Financial Year ended March 31, 2023 as compared to Rs.49.74 for the Financial Year ended March 31, 2022.

Financials	Year Ended FY2023	Year Ended FY2022	% Change
Total Income	₹1200.9462 crs	₹953.1534 crs	26.00%
Net Profit	₹163.5176 crs	₹63.8220 crs	156.21%
EPS	₹127.45	₹49.74	156.23%

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 2128.80 as compared to the previous close of Rs. 2161.60. The total number of shares traded during the day was 7141 in over 1497 trades.

The stock hit an intraday high of Rs. 2240.00 and intraday low of 2118.35. The net turnover during the day was Rs. 15593560.00.